JournalScan
| The first 150 words of the full text of this article appear below. |
ISCHAEMIC HEART DISEASE

After a spate of new inflammatory markers that appear to predict risk, this study of a very high risk population of patients (8% death rate at 12 months) having coronary angiography, suggests that having low levels of endothelial progenitor cells in your blood elevates cardiovascular risk. After adjustment for age, sex, vascular risk factors, and other relevant variables, increased levels of endothelial progenitor cells were associated with a reduced risk of death from cardiovascular causes (hazard ratio (HR) 0.31, 95% confidence interval (CI) 0.16 to 0.63; p = 0.001), a first major cardiovascular event (HR 0.74, 95% CI 0.62 to 0.89; p = 0.002), revascularisation (HR 0.77; 95% CI 0.62 to 0.95; p = 0.02), and hospitalisation (HR 0.76, 95% CI 0.63 to 0.94; p = 0.01). Endothelial progenitor cell levels were not predictive of MI or of death from all causes. This marker is not yet ready for "prime
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
